Human Voice vs AI-Cloned Voice Audio Added to Written Consent Before Ureteroscopy or Retrograde Intrarenal Surgery (AUDIO-CONSENT)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAydin Adnan Menderes University

About this trial

Before kidney stone surgery with a flexible or semirigid ureteroscope, patients must read and sign a written consent form, but many patients find these forms long and hard to understand. This study tests whether listening to an audio recording of the same consent form, in addition to the usual written form and the surgeon's explanation, helps patients understand the operation better. It also asks whether it matters if the recording is read by a real urologist or produced by artificial intelligence (AI) from a clone of that same urologist's voice.

Adults scheduled for their first ureteroscopy or retrograde intrarenal surgery at three hospitals in Turkey will be randomly assigned to one of three groups: (A) standard written consent only, (B) standard consent plus an audio recording read by a urologist, or (C) standard consent plus the same text produced by an AI-cloned version of the same urologist's voice. All three groups receive exactly the same information, word for word; only the way it is delivered differs. Patients in group C are told that the voice was produced by AI.

The main outcome is a 10-question knowledge test on the content of the consent form, taken immediately after the consent process. Anxiety (State-Trait Anxiety Inventory) and satisfaction are also measured on the same day. No forms are completed on the day of surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age 18 years or older

Scheduled for elective ureteroscopy (URS) or retrograde intrarenal surgery (RIRS)

Able to read, understand and communicate verbally in Turkish

Provides written informed consent to participate in the study

Disqualifiers

Hearing or visual impairment preventing use of the study materials

Confusion, dementia, psychosis or any other condition affecting capacity to consent

Emergency surgery

Previous URS or RIRS

Trial design

Design model

Parallel

Treatments tested in this trial

  • Standard written informed consent

    Other intervention

    The institution's unified written informed consent form for ureteroscopy and retrograde intrarenal surgery, read and signed by the patient, together with the physician's usual verbal explanation. Delivered identically in all three arms.

  • Human-voice audio consent recording

    Behavioral

    An approximately 12-minute audio recording of the complete consent text, read word for word by one urologist (the same recording at all centers; not the patient's own surgeon). Presented after the standard written consent and physician explanation, on a tablet with headphones in the patient's room without companions; the patient may replay it and the number of replays is recorded. Loudness-normalized to -24 LUFS. Introduced to the patient as "a recording of the entire consent form read by a urologist".

  • AI-cloned-voice audio consent recording

    Behavioral

    The same consent text, generated once with Resemble.ai from a voice clone of the same urologist (reference sample: a separate recording of at least 5 minutes of a different text), frozen before enrollment with no live AI calls. Duration approximately 12 minutes; loudness-matched (-24 LUFS), codec and delivery identical to the human-voice recording, presented after the standard written consent and physician explanation, on a tablet with headphones; replay allowed and counted. Patients are informed that the voice was generated with AI from a urologist's voice.

Treatment groups

240 Participants
are divided into 3 treatment groups
Group A: A: Written consent (standard care)Active comparator 1 intervention
Group B: B: Written consent + urologist-read audioExperimental treatment 2 interventions
Group C: C: Written consent + AI-cloned voice audioExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Post-consent knowledge score

Score on a 10-item multiple-choice test derived from the consent text (range 0-10; higher scores indicate better knowledge of the procedure, its risks, alternatives and patient responsibilities). Each item is mapped to a specific paragraph of the consent form. Analyzed as a continuous variable.

Time frame
Day of consent, immediately after completion of the consent process (before surgery)

Secondary outcomes

1

Post-consent state anxiety (STAI-S)

State-Trait Anxiety Inventory, State form (Turkish version, Öner \& Le Compte), range 20-80; higher scores indicate greater anxiety. Measured immediately after the consent process and analyzed adjusted for the pre-consent STAI-S score (measured immediately before the consent process) and STAI-T.

Time frame
Day of consent, immediately after the consent process
2

Patient satisfaction and perceived clarity

Three study-specific 5-point items (perceived clarity of the information, adequacy of the information for decision-making, overall satisfaction with the consent process); each scored 1-5, higher scores indicate better outcomes. Reported item by item; total score (3-15) secondary. Not validated.

Time frame
Day of consent, immediately after the consent process
3

Perceived naturalness and usefulness of the audio recording (arms B and C)

Two study-specific 5-point items: naturalness of the voice (1 = not at all natural to 5 = completely natural) and usefulness of receiving the information as audio (1 = not at all to 5 = very much). Higher scores indicate greater perceived naturalness/usefulness. Asked in both audio arms.

Time frame
Day of consent, immediately after the consent process
4

Acceptability of the AI-generated voice (arm C)

Single study-specific 5-point item: "Did it bother you that the voice was generated by artificial intelligence?" (1 = not at all to 5 = very much; higher scores indicate lower acceptability). Administered on a separate sheet after the naturalness items have been collected.

Time frame
Day of consent, immediately after the consent process

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Aydin Adnan Menderes University

Lead sponsor

Aydin City Hospital

Collaborator

Kutahya Health Sciences University

Collaborator